Brief introduction: gadolinium spray gluamine injection (magnetic phloglucamine) produced by Beiriku is the first magnetic resonance contrast agent approved by the Ministry of Health in China.Since its launch at the end of 1992, it has rapidly occupied the market with its excellent product quality and reasonable price, and has been safely applied more than 10 million cases, with good clinical enhancement effect and few side effects.

Indications: Used for magnetic resonance imaging of central nervous system (brain and spinal cord), abdomen, chest, pelvic cavity, limbs and other human organs and tissues.

Usage and dosage: Intravenous injection, generally 0.2 ml per kg body weight.

Adverse reactions: facial flushing, headache, urticaria, nausea, vomiting, bronchospasm, palpitation, dizziness and anaphylactic shock may occur.

Contraindications: It is contraindicated for people allergic to this product.

Precautions: Use with caution in patients with renal insufficiency.